Abstract
SAT-183 - Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s0168-8278(23)03298-1
Journal: Journal of Hepatology | Publication Date: Jun 1, 2023 |
SAT-183 - Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis
Join us for a 30 min session where you can share your feedback and ask us any queries you have